“A V/Q scan can be the first choice—but the CT angiogram is the classic choice—for diagnosing a pulmonary embolism,” noted H. Dirk Sostman, a professor of radiology and executive vice dean at Weill Cornell Medical College in New York City and chief academic officer at the Methodist Hospital in Houston, Texas. “A ‘very low probability’ V/Q lung scan—together with a ‘low probability’ objective clinical assessment—is as reliable as a CT angiogram and allows a doctor to evaluate whether a pulmonary embolism is present or not,” added Alexander Gottschalk, a professor of diagnostic radiology at Michigan State University in East Lansing.
A noninvasive V/Q scan involves two tests using radioactive material to measure breathing (ventilation) and circulation (perfusion) in all areas of the lungs, said Gottschalk, who has performed research with studies like the Prospective Investigation of Pulmonary Embolism Diagnosis (PIOPED) project for more than 30 years. V/Q scans reduce the radiation to the breast by about 70 times on average compared to higher-radiation procedures such as computed tomography pulmonary angiography (CTA), he explained.
“While CTA is the major test used widely to detect pulmonary embolisms, it is associated with higher radiation risk, especially for young women of reproductive age,” said Gottschalk. “The combination of a low probability V/Q scan and low probability clinical assessment is extremely effective,” said Sostman. “Our study is important for doctors—and their patients—since tests show that high radiation doses to the breast from CT, especially important in young women, may increase their risk of breast cancer,” he added.
A pulmonary embolism is a sudden blockage in a lung artery, usually occurring when a blood clot travels to the lung from a vein in the leg. This condition can cause permanent damage to a part of the lung. And, if a blood clot is large—or if they are numerous—a pulmonary embolism can cause death. According to statistics, at least 100,000 cases of pulmonary embolism take place each year in this country, and it is considered the third most common cause of death in hospitalized patients. A person’s risk at getting a pulmonary embolism doubles every 10 years after the age of 60.
In their study, Gottschalk and Sostman analyzed the prospectively gathered data from PIOPED II, a large-scale, multicenter trial. “Very Low Probability Interpretation of Ventilation Perfusion Lung Scans in Combination With Low Probability Objective Clinical Assessment Reliably Excludes Pulmonary Embolism: Data From PIOPED II” appears in the September issue of the Journal of Nuclear Medicine, which is published by SNM, the world’s largest molecular imaging and nuclear medicine society. Additional co-authors include Paul D. Stein, St. Joseph Mercy Oakland Hospital, Pontiac, Mich., Wayne State University, Detroit, Mich.; and Fadi Matta and Afzal Beemath, St. Joseph Mercy Oakland Hospital, Pontiac, Mich.
Media representatives: To obtain a copy of this article, please contact Maryann Verrillo by phone at (703) 652-6773 or send an e-mail to firstname.lastname@example.org. Current and past issues of the Journal of Nuclear Medicine can be found online at jnm.snmjournals.org. Print copies can be obtained by contacting the SNM Service Center, 1850 Samuel Morse Drive, Reston, VA 20190-5316; phone (800) 513-6853; e-mail email@example.com; fax (703) 708-9015. A subscription to the journal is an SNM member benefit.
About SNM—Advancing Molecular Imaging and Therapy
SNM is an international scientific and professional organization of more than 16,000 members dedicated to promoting the science, technology and practical applications of molecular and nuclear imaging to diagnose, manage and treat diseases in women, men and children. Founded more than 50 years ago, SNM continues to provide essential resources for health care practitioners and patients; publish the most prominent peer-reviewed journal in the field (Journal of Nuclear Medicine); host the premier annual meeting for medical imaging; sponsor research grants, fellowships and awards; and train physicians, technologists, scientists, physicists, chemists and radiopharmacists in state-of-the-art imaging procedures and advances. SNM members have introduced—and continue to explore—biological and technological innovations in medicine that noninvasively investigate the molecular basis of diseases, benefiting countless generations of patients. SNM is based in Reston, Va.; additional information can be found online at http://www.snm.org.
Maryann Verrillo | EurekAlert!
Speed data for the brain’s navigation system
06.12.2016 | Deutsches Zentrum für Neurodegenerative Erkrankungen e.V. (DZNE)
Study suggests possible new target for treating and preventing Alzheimer's
02.12.2016 | Oregon Health & Science University
In recent years, lasers with ultrashort pulses (USP) down to the femtosecond range have become established on an industrial scale. They could advance some applications with the much-lauded “cold ablation” – if that meant they would then achieve more throughput. A new generation of process engineering that will address this issue in particular will be discussed at the “4th UKP Workshop – Ultrafast Laser Technology” in April 2017.
Even back in the 1990s, scientists were comparing materials processing with nanosecond, picosecond and femtosesecond pulses. The result was surprising:...
Have you ever wondered how you see the world? Vision is about photons of light, which are packets of energy, interacting with the atoms or molecules in what...
A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.
Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...
In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.
“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...
The Max Planck Institute for Physics (MPP) is opening up a new research field. A workshop from November 21 - 22, 2016 will mark the start of activities for an innovative axion experiment. Axions are still only purely hypothetical particles. Their detection could solve two fundamental problems in particle physics: What dark matter consists of and why it has not yet been possible to directly observe a CP violation for the strong interaction.
The “MADMAX” project is the MPP’s commitment to axion research. Axions are so far only a theoretical prediction and are difficult to detect: on the one hand,...
16.11.2016 | Event News
01.11.2016 | Event News
14.10.2016 | Event News
07.12.2016 | Earth Sciences
07.12.2016 | Earth Sciences
07.12.2016 | Materials Sciences